Randomized, placebo-controlled, double-blind trial of clobetasol propionate 0.05% in the treatment of oral lichen planus

Randomized, placebo-controlled, double-blind trial of clobetasol propionate 0.05% in the treatment of oral lichen planus

Objective: To perform a randomized, placebo-controlled, double-blind study, with a follow-up period of 6 months, for the use of topical clobetasol in cases of symptomatic oral lichen planus (OLP). Subjects and Methods: Thirty-two participants were analyzed, with the aims of: (I) to compare the usefu...

Full description

Bibliographic Details
Main Authors: Arduino, P.G (Author), Broccoletti, R. (Author), Cabras, M. (Author), Campolongo, M.G (Author), Carbone, M. (Author), Carossa, S. (Author), Conrotto, D. (Author), Gambino, A. (Author), Ricceri, F. (Author), Sciannameo, V. (Author)
Format: Article
Language:English
Published: Blackwell Publishing Ltd 2018
Subjects:
Administration, Topical
adult
aged
Aged
antiinflammatory agent
Anti-Inflammatory Agents
Article
clinical article
clobetasol
Clobetasol
clobetasol propionate
controlled study
double blind procedure
Double-Blind Method
drug withdrawal
erythema
female
Female
follow up
gastroesophageal reflux
glucose
glucose blood level
human
Humans
hydroxyethylcellulose
lichen planus
Lichen Planus, Oral
male
Male
medication compliance
middle aged
Middle Aged
oral lichen planus
outcome
patient compliance
placebo
priority journal
randomized controlled trial
remission
side effect
symptomatic
topical drug administration
treatment outcome
Treatment Outcome
Online Access:View Fulltext in Publisher

Similar Items

Similar Items